Efavirenz and Nevirapine in HIV-1 Infection: Is There a Role for Clinical Pharmacokinetic Monitoring?

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.46, Iss.2, 2007-01, pp. : 109-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nevirapine unsafe for HIV-1 infection prophylaxis?

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Efavirenz-containing regimens superior in HIV-1 infection?

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

`Pokeweed' for HIV-1 infection?

Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Can Pharmacokinetic Monitoring Improve Clinical Use of Fluorouracil?

By Young A.M. Daryanani S. Kerr D.J.

Clinical Pharmacokinetics, Vol. 36, Iss. 6, 1999-06 ,pp. : 391-398

Adis International

Access to resources Recommend Favorite

Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia?

By Schwenger Erin Dumontet Jane Ensom Mary H.H.

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 415-428

Adis International

Access to resources Recommend Favorite